|
TAB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.68369999999918E-05 |
| Normal-vs-Stage3 |
2.480700E-03 |
| Normal-vs-Stage4 |
1.115800E-01 |
| Stage1-vs-Stage2 |
7.835600E-02 |
| Stage1-vs-Stage3 |
5.882100E-02 |
| Stage1-vs-Stage4 |
2.159000E-01 |
| Stage2-vs-Stage3 |
6.515400E-01 |
| Stage2-vs-Stage4 |
6.527800E-01 |
| Stage3-vs-Stage4 |
8.700800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.3586021196943E-11 |
| Normal-vs-Asian |
1.655670E-02 |
| Caucasian-vs-AfricanAmerican |
5.630400E-01 |
| Caucasian-vs-Asian |
8.857400E-01 |
| AfricanAmerican-vs-Asian |
7.269600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.34760000047862E-07 |
| Male-vs-Female |
2.596800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.40250003119758E-09 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
3.49509999830744E-08 |
| Normal-vs-Extreme_Obese |
1.52350000393042E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.007000E-01 |
| Normal_Weight-vs-Obese |
3.394400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.573800E-01 |
| Extreme_Weight-vs-Obese |
2.704200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.450000E-01 |
| Obese-vs-Extreme_Obese |
3.215200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.870100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.63336011382853E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
5.36004574058779E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.497400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.630610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.192500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.370400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.499900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.242800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
7.56390505785021E-11 |
| Normal-VS-KIRP CIMP |
8.394200E-01 |
| Normal-VS-Unclassified PRCC |
2.47409999999393E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.785500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.666370E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.207900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.829900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.100800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.977850E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62792002100787E-12 |
| Normal-vs-N1 |
2.067600E-01 |
| Normal-vs-N2 |
1.27610000000278E-06 |
| N0-vs-N1 |
5.302900E-03 |
| N0-vs-N2 |
7.842400E-01 |
| N1-vs-N2 |
1.634750E-01 |
|
|
